Medical Data Vision Co., Ltd.
3902.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | ¥5,907 | ¥6,419 | ¥6,105 | ¥5,672 |
| % Growth | -8% | 5.2% | 7.6% | – |
| Cost of Goods Sold | ¥1,576 | ¥1,388 | ¥1,075 | ¥1,029 |
| Gross Profit | ¥4,331 | ¥5,031 | ¥5,030 | ¥4,644 |
| % Margin | 73.3% | 78.4% | 82.4% | 81.9% |
| R&D Expenses | ¥290 | ¥68 | ¥333 | ¥317 |
| G&A Expenses | ¥3,529 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥4,037 | ¥3,192 | ¥2,939 | ¥2,733 |
| Sales & Mktg Exp. | ¥508 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥1 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥4,328 | ¥3,260 | ¥3,272 | ¥3,050 |
| Operating Income | ¥4 | ¥1,771 | ¥1,758 | ¥1,594 |
| % Margin | 0.1% | 27.6% | 28.8% | 28.1% |
| Other Income/Exp. Net | -¥731 | -¥203 | -¥331 | -¥2 |
| Pre-Tax Income | -¥727 | ¥1,568 | ¥1,427 | ¥1,592 |
| Tax Expense | ¥76 | ¥614 | ¥570 | ¥492 |
| Net Income | -¥791 | ¥979 | ¥871 | ¥1,087 |
| % Margin | -13.4% | 15.3% | 14.3% | 19.2% |
| EPS | -20.73 | 25.63 | 22.77 | 27.74 |
| % Growth | -180.9% | 12.6% | -17.9% | – |
| EPS Diluted | -20.73 | 25.63 | 22.76 | 27.74 |
| Weighted Avg Shares Out | 38 | 38 | 38 | 39 |
| Weighted Avg Shares Out Dil | 38 | 38 | 38 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥127 | ¥102 | ¥150 | ¥136 |
| EBITDA | ¥130 | ¥1,872 | ¥1,908 | ¥1,727 |
| % Margin | 2.2% | 29.2% | 31.3% | 30.5% |